Braskem SA (BAK) stock
BAKNYSEIndustrial Organic ChemicalsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Score 0/30
$1.13+0.00 (0.00%)
Close on Nov 13, 2026Market cap $510.39MP/E –Yield –
Braskem r&d expenses
Research and development expenses are spending on new products and technology.
Braskem's R&D Expenses for the twelve months ending Dec 31, 2021 was 297.00M BRL, up 18.5% year over year. For fiscal 2025 it was 460.00M BRL, down 0.6% from the year before. Over ten years it grew 10.5% a year on average. The highest annual figure on record is 463.00M BRL in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 460.00M BRL | -0.6% |
| FY2024 | Dec 31, 2024 | 463.00M BRL | +20.9% |
| FY2023 | Dec 31, 2023 | 383.00M BRL | +2.4% |
| FY2022 | Dec 31, 2022 | 374.00M BRL | +25.9% |
| FY2021 | Dec 31, 2021 | 297.00M BRL | +18.5% |
| FY2020 | Dec 31, 2020 | 250.65M BRL | +1.2% |
| FY2019 | Dec 31, 2019 | 247.73M BRL | +13.0% |
| FY2018 | Dec 31, 2018 | 219.26M BRL | +30.9% |
| FY2017 | Dec 31, 2017 | 167.46M BRL | +3.4% |
| FY2016 | Dec 31, 2016 | 162.01M BRL | -4.5% |
| FY2015 | Dec 31, 2015 | 169.64M BRL | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | 99.01M BRL | – |
| Q4 FY2020 | Dec 31, 2020 | 77.79M BRL | – |
See a number that looks wrong?